Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 06:29 am Sale | 13G | INARI MED INC NARI | Point72 Asset Management L.P. | 1,175,150 2% | -1,620,202 (-57.96%) | View |
| 2024-02-14 06:17 am Sale | 13G | PULMONX CORP LUNG | Point72 Asset Management L.P. | 1,546,089 4% | -425,721 (-21.59%) | View |
| 2024-02-14 06:16 am Sale | 13G | IOVANCE BIOTHERAPEUTICS INC CO IOVA | Point72 Asset Management L.P. | 468,821 0.2% | -7,646,069 (-94.22%) | View |
| 2024-02-14 06:15 am Sale | 13G | FASTLY INC FSLY | Point72 Asset Management L.P. | 68,184 0.1% | -6,141,507 (-98.90%) | View |
| 2024-02-14 06:11 am Sale | 13G | ESPERION THERAPEUTICS INC ESPR | Point72 Asset Management L.P. | 209,971 0.2% | -4,323,785 (-95.37%) | View |
| 2024-02-14 06:03 am Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Point72 Asset Management L.P. | 825,000 3.8% | -425,000 (-34.00%) | View |
| 2024-02-14 06:01 am Sale | 13G | CUTERA INC CUTR | Point72 Asset Management L.P. | 214,800 1.1% | -929,607 (-81.23%) | View |
| 2024-02-12 4:24 pm Purchase | 13G | ANNEXON INC ANNX | Point72 Asset Management L.P. | 4,868,603 6.2% | 4,868,603 (New Position) | View |
| 2024-02-09 4:08 pm Purchase | 13G | VACCINEX INC VCNX | Point72 Asset Management L.P. | 5,793,452 9.9% | 5,793,452 (New Position) | View |
| 2024-02-08 4:53 pm Purchase | 13G | JOYY INC ADS REPSTG COM YY | Point72 Asset Management L.P. | 45,329,900 5.1% | 45,329,900 (New Position) | View |
| 2024-02-07 4:25 pm Purchase | 13G | ALTO NEUROSCIENCE INC ANRO | Point72 Asset Management L.P. | 1,692,778 6.3% | 1,692,778 (New Position) | View |
| 2024-02-05 4:34 pm Purchase | 13G | SAGIMET BIOSCIENCES INC SER A SGMT | Point72 Asset Management L.P. | 1,612,639 5.3% | 1,612,639 (New Position) | View |
| 2024-01-31 4:55 pm Purchase | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | Point72 Asset Management L.P. | 850,001 6.3% | 850,001 (New Position) | View |
| 2024-01-31 4:54 pm Purchase | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | Point72 Asset Management L.P. | 4,867,706 5.2% | 3,680,108 (+309.88%) | View |
| 2024-01-29 4:40 pm Purchase | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | Point72 Asset Management L.P. | 388,676 8.8% | 388,676 (New Position) | View |
| 2024-01-25 4:19 pm Purchase | 13G | FATE THERAPEUTICS INC FATE | Point72 Asset Management L.P. | 4,945,146 5% | 4,945,146 (New Position) | View |
| 2024-01-04 4:15 pm Purchase | 13G | C4 THERAPEUTICS INC CCCC | Point72 Asset Management L.P. | 2,676,696 5.4% | 2,676,696 (New Position) | View |
| 2024-01-02 4:15 pm Purchase | 13G | SYROS PHARMACEUTICALS INC SYRS | Point72 Asset Management L.P. | 1,471,771 5.7% | 1,471,771 (New Position) | View |
| 2023-12-28 4:15 pm Purchase | 13G | PAGSEGURO DIGITAL LTD PAGS | Point72 Asset Management L.P. | 10,702,598 5.1% | 8,012,692 (+297.88%) | View |
| 2023-12-18 4:15 pm Purchase | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | Point72 Asset Management L.P. | 3,186,077 5.5% | 2,818,071 (+765.77%) | View |